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ABSTRACT 
Fibrosarcoma of the breast is a rare entity. Prognosis of fibrosarcoma of the breast is poor and the role of various 
treatment modalities is not clearly defined due to the rarity of the disease. It must be differentiated  from  other 
stromal tumours like malignant phylloid tumour, Malignant fibrous histiocytoma and pleomorphic 
rhabdomyosarcoma, liposarcoma, leiomyosarcoma. One such case is presented here. Primary sarcomas of the breast 
are extremely rare and account for less than 0.1% of all malignant tumours of the breast of which the conversion of a 
phyllodes tumour to sarcoma of the breast is even rarer and only two such case has ever been reported.  
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Case report  
A 45-year-old female presented at our institution for 
recurrent tumours in the left breast she complained of 
pain at the operative site. On examination, a ulcerated 
scar was present with mild induration. Palpable axillary 
lymph nodes were present. No abnormality was 
detected abdominally or in the right breast. A complete 
systemic examination of the patient did not show any 
other abnormality. The FNAC diagnosis from the last 
operative specimen was Phylloid tumour of the breast. 
Than patient present with recurrent swelling of breast 
,with ulcerated scar. Systemic examination shows mild 
anemia, other investigation like total leukocyte count, 
platelet count are within normal limit. Biochemical 
examinations like urea, creatinine, FBS, Serum 
sodium, Serum potassium are within normal limit. The 
X-rays of the chest were normal. After modified radical 
mastectomy 10% formalin fixed specimen was send to 
our department. Weight of specimen 1.94 kg. Grossly it 
measures 20.0X15.0X12.0 CM. Skin covered area 
measuring 20.0X 7.0 cm. Ulcerated area identified 
measuring 8.0 X 6.0 cm. nipple ,areola cannot 
identified due to presence of ulceration.  
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On cut homogenous, gray white involving whole breast 
with whorling pattern at places. Multiple sections are 
taken from gray white area and one sections are taken 
from anterior, posterior, superior, inferior, medial and 
lateral margins.4 lymphnodes identified size varies 
from 0.5 to 0.3 cm. After processing H &E stained 
sections studied under light microscope shows tumour 
cells spindloid to ovoid arranged in form of fascicles, 
cells interlacing at acute angle giving appearance of 
herring bone pattern. Along with trabecule, sheets and 
clusters. Individual malignant cells are highly 
pleomorphic varying in size and shape, having 
eccentric to centrally located, hyperchromatic, 
elongated nuclei, scanty to moderate amount of 
cytoplasm, indistinct cell border and altered 
nucleocytoplasmic ration. Mitotic count 12-14mitotic 
count/10 HPF with few atypical mitotic figure. Fare  
number of tumour giant cells also appreciated. 
Adjoining area shows  proliferating fibrocollagenous 
tissue. No other epithelial component identified after 
multiple sections studied.Features are of Fibrosarcoma. 
All margins show tumour invasion and 4/4 lymph node 
shows tumour deposit. Differential diagnosis include- 
malignant Phylloid tumour and metaplastic tumour 
excluded because of absence of epithelial conmponent. 
Malignant fibrous histiocytoma excluded because of 
absence of histiocytes, lymphocytes, plasma cells and 
cells are not arranged in cart wheel pattern. 
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Discussion 
 
Phyllodes tumours, despite being benign, have a 
tendency to recur after surgery. An originally 
histologically benign tumour may develop malignant 
features with recurrence. The literature shows that in 
most cases more aggressive growth and enhanced 
malignancy is found on recurrence [1-2]. Recurrences 
may result from proliferative remnants of the primary 
tumour following local excision or they may be de-
novo tumours induced by an extra-tumoural stromal 
hypercellularity resulting ina new benign cystosarcoma 
phyllodes [3]. They behave more like soft tissue 
sarcomas rather than tumours arising from the 
glandular tissue of the breast [4]. Metastases have been 
observed in 19% of malignant phyllodes tumour [3]. 
The interval between the diagnosis of the primary 
tumour and identification of metastases ranged from 
seven months to five years, whereas the interval 
between recurrent tumour and metastases was from 6 
to 24 months or in some cases matastases were present 
simultaneously [3]. Very rarely, the malignant potential 
increases and results in the conversion to a sarcoma of 
the breast. Fibrosarcomas are amongst some of the 
most rare tumours of the breast. Any breast neoplasia 
that does not display characteristics of a fibroadenoma 
are designated stromal sarcoma of which fibrosarcomas 
are a small percentage. They may occur at any age, but 
are commonly seen in women between 40 and 50 years 
[5]. There are no characteristic features that clinically 
distinguish them from other breast tumours. Metastases 
from fibrosarcoma breast are commonly seen in the 
lung but may occur in the brain, kidney and the bone; 
lymphatic spread is rare [5]. The prognosis for 
fibrosarcoma of the breast is poor and the role of 
various treatment modalities is not clearly defined due 
to rarity of disease [6]. Tumour size may be more 
important prognostic factor than tumour grade [2]. 
Distant metastases are developed in 3.2%, 11.1% and 
in 28.6% of patients with benign, borderline and 
malignant phyllodes tumours, respectively [6-8]. With 
histopathological conversion to a sarcoma, the chances 
of distant metastases increase.  
 
Conclusion 
Phyllodes tumour of the breast has a tendency for 
recurrence after surgery with increased malignant 
potential. In rare instances, it may convert to 
fibrosarcoma of the breast. 
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Fig1:Gross specimen of previously resected specimen                                         Fig2: Microscopy of previously resected  
specimen               
                                                                                                                                   shows Phylloid Tumour 
 
 
                                                     
Fig3: Specimen of recurrent mass.                                                                      Fig4:Whorling pattern      
                          
  Fig5:Herring bone pattern                      Fig6:Hyperchromatic spindloid nuclei              Fig 7:Hyperchromatic ovoid cells, giant  
                                                                                                                                                                         Cell and mitotic figure 
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